Search Results
Results found for "positive allosteric modulators"
- Dr. Bianca Plouffe | Dr. GPCR Ecosystem
In 2021, Bianca secured a permanent position as a lecturer.
- Scaling GLP 1 Receptor Tools Through Academia Industry Collaboration | Dr. GPCR Ecosystem
validation in GPCR assay design Building reagents that must work in complex tissues, not just simplified models Her work centers on GPCR modulators, synthetic chemistry, and enabling robust biological assays through
- Eurofins DiscoverX | Dr. GPCR | Dr. GPCR Ecosystem
GPCR Product Solutions Determine rank-order hits, evaluate ligand bias or allostery, study multiple targets
- ep 175 with jens carlsson clip 2 | Dr. GPCR Ecosystem
At Uppsala University, Jens Carlsson’s lab uses modeling to shape experiments—not just explain them. Home → Flash News → ep 175 with jens carlsson clip 2 If your model can’t change an experiment, what’s GPCR Podcast If your model can’t change an experiment, what’s the point? That’s the standard Dr. For him, modeling isn’t just about elegant simulations; it’s about impact . His team is clear about the capabilities and limitations of their models, an honesty that builds long-term
- master gpcr pharmacologic models before its too late | Dr. GPCR Ecosystem
Home → Flash News → master gpcr pharmacologic models before its too late Published on July 11, 2025 Category They’re stalling because of slow decisions, misapplied models, and buried priorities. Terry’s Corner breaks down the 4 pharmacologic models that separate forecasting from guessing. Dr. ✳️ Read the Weekly News → https://www.ecosystem.drgpcr.com/post/crush-data-confusion-conquer-gpcr-drug-discovery
- Cannabinoid compounds to augment L-DOPA treatment in Parkinson's Disease
Marc Caron at Duke University for his post-doctoral training. In the Caron lab, Dr. Toronto and has continued working on dopamine transmission and homeostasis and the role of several of key modulators
- Developing a PROTAC to Degrade the Constitutively Active Onco-GPCR in Uveal Melanoma
Fellowship to develop novel methods of synthesizing 2-imidazoline scaffolds to be used as proteasome modulators
- ep 175 with jens carlsson clip 3 | Dr. GPCR Ecosystem
AI is transforming GPCR modeling. For decades, molecular modeling focused on explaining — rationalizing why a ligand binds, why a mutation With tools like AlphaFold , his lab can now model receptor–peptide complexes in seconds — an achievement A good model doesn’t just match published structures; it forecasts new biology, new ligands, and new insight reframes what “success” in computational pharmacology really means. 👉 Watch the full episode: model
- Dr. John Streicher | Dr. GPCR Ecosystem
downstream of the opioid receptors work, including the unique organization of chaperone protein Hsp90 modulation
- GPCR location matters with Dr. Gabriele Kockelkoren | Dr. GPCR Ecosystem
Importantly, my work revealed heterogeneous spatial patterns of receptor density and activation, that are modulated
- Pharmacological and Genetic Preclinical Models of Ghrelin Receptor Functional Selectivity to Investigate Metabolic Disease Pathophysiology
Committee Sponsors GPCR Retreat Program < Back to schedule Pharmacological and Genetic Preclinical Models
- ep 175 with jens carlsson clip 1 | Dr. GPCR Ecosystem
Home → Flash News → ep 175 with jens carlsson clip 1 Can your model actually predict the outcome of a Can your model actually predict the outcome of a GPCR experiment? At Uppsala University, Dr. Jens Carlsson and his team are redefining what computational modeling means in drug discovery. models have too often served as post hoc rationalizations. His team is candid about the limits of their models.
- Self-Learning, Collaboration, and Delegation in Science with Dr. Badr Sokrat | Dr. GPCR Ecosystem
importance of choosing a city one would like to live in for several years when deciding on a postdoc position Additionally, they both agreed on the importance of mentorship in building confidence, with Yamina sharing her positive
- ep 175 with jens carlsson release picture | Dr. GPCR Ecosystem
Home → Flash News → ep 175 with jens carlsson release picture Model. Predict. But in the quiet hours, he found himself drawn to the structures, to the models, to figuring out why Professor of Computational Biochemistry at Uppsala University , where his lab uses structure-based modeling GPCR Podcast : https://www.ecosystem.drgpcr.com/dr-gpcr-podcast/model-predict-discover #DrGPCR #GPCR
- Yamina's Corner | Dr. GPCR Ecosystem
Organizations Elevate Scientific Offerings: Refine and optimize your GPCR assay platforms and in vitro models Differentiate Your Market Position: Showcase your specialized GPCR expertise to stand out from competitors
- terrys corner predict drug behavior | Dr. GPCR Ecosystem
Dive into the logic of drug modeling with Terry Kenakin. In his latest lesson, he breaks down the essential models shaping modern pharmacology.
- Weekly News October 23 | Dr. GPCR Ecosystem
Jens Carlsson's take on predictive modeling. Jens Carlsson on predictive modeling—where structure-based design and MD guide experiments (and where If you’re advancing covalent or tight-binding candidates—or building models meant to predict, not narrate
- Dr. Françoise Bachelerie | Dr. GPCR Ecosystem
identified the orphan CXCR7/ACKR3 receptor as being the 2nd receptor for CXCL12, which behaves as a modulator
- Session IV | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
During my Bachelor's in 2018, I sought practical lab experience and found a position as a student assistant
- Student Flash Presentations | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
To test this, an LFS mouse model (germline Tp53 deletion) with a second floxed allele under the control Preliminary findings indicate that the simultaneous loss of Bai3 and Tp53 expression in our mouse model A mouse model of Zhu-Tokita-Takenouchi-Kim syndrome reveals indispensable SON functions in organ development He is also interested in working on Glioma Brain Organoid models." Hailey Steichen Abstract "Adhesion G protein-coupled receptors (aGPCRs) are important and understudied modulators
- Dr. Katarina Nemec | Dr. GPCR Ecosystem
screens with state-of-the-art microscopy and high throughput screening to explain novel ways of GPCR modulation
- Unveiling Non-Canonical Functions for Gαq Signaling Pathways
in the journal Nature Communications (12 (1):4540, 2021) with the title "Gαq controls autophagy via modulation
- Full Agenda for Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
Physiological and pathological roles of AGPCRs in the nervous system Beatriz Blanco Redondo · Willem Berend Post Approach (MS-BRET) Florian Seufert Unveiling the GPS Cleavage Mechanism in ADGRL1 with QM/MM Willem Berend Post Caroline Formstone Interrogating The Role Of CELSR1 (ADGRC1) In Breast Cancer Mariam Melkumyan GPR110 modulates TNIK Sumit Bandekar Structural studies of the CELSR1 extracellular region reveal a compact multidomain module regulates signaling Nicole Perry-Hauser Adhesion G protein-coupled receptor latrophilin-3 (ADGRL3) modulation
- Dr. Nyla Naim, Dr. Michael Lemieux & Dr. Jason Nasse | Dr. GPCR Ecosystem
in Neuroscience from Ohio State University focusing on synaptic plasticity and adrenergic receptor modulation
- Dr GPCR Ecosystem Feedback | Dr. GPCR Ecosystem
Your Needs What topics or training modules would you like us to add next?
- Affiliate Policy | Dr. GPCR Ecosystem
Join us to make a positive impact while earning commissions. << Back Affiliate Policy Dr. GPCR Ecosystem; Sites with content related to sexual, religious, political, or other sensitive matters
- Media Partner Packages | Dr. GPCR Ecosystem
Ecosystem ✓ Logo, branding, and description of your mission ✓ Contact links and key highlights ✨ Logo positioning clarity, and purpose ✓ Bonus: Mentioned in podcast intros/outros 📣 Social Media Promotion ✓ Engaging posts Scientists Premium Accounts ✓ 3 Non-Scientists Premium Accounts 📝 Blog Contributions ✓ Contribute to blog posts
- 🎯 Crack the code of GPCR ligand development! In case you haven’t heard, Dr. Terry Kenakin is hosting a 4-week course on GPCR drug development—and registration closes in 3 days! ⚠️ What you’ll learn: ✅ Drug absorption, metabolism & clearance ✅ PK-PD modeling & therapeutic profiles ✅ Early safety assessments & toxicity risks 📌 Limited spots—sign up before March 18th! 👉 Development of GPCR Ligands as Therapeutic Drugs | Dr. GPCR Ecosystem #GPCR #DrGPCR #Pharma #Biotech #Research | Dr. GPCR Ecosystem
⚠️ What you’ll learn: ✅ Drug absorption, metabolism & clearance ✅ PK-PD modeling & therapeutic profiles ⚠️ What you’ll learn: ✅ Drug absorption, metabolism & clearance✅ PK-PD modeling & therapeutic profiles
- Donate to Dr GPCR — Support the GPCR Community & University
- $250+ 👉 Expands Dr GPCR University with new lessons, updated materials, and interactive learning modules
- Dr. Amynah Pradhan | Dr. GPCR Ecosystem
Her next career step took her to AstraZeneca as a postdoctoral trainee, where she studied animal models Andrew Charles that who specialized in animal models of migraine and delta-opioid receptors as a therapeutic














